Aerolyk

The tissue distribution of TLR expression in normal human tissues has been examined using PCR by the codiscoverers of TLR7, 8, and 9. Studies by these and other investigators have concluded that human hTLR9 mRNA has a more limited tissue expression profile than any of the other TLRs: In contrast to all the other hTLRs, the hTLR9 is preferentially expressed in immune-cell-rich tissue including spleen, lymph node, bone marrow, and peripheral blood leukocytes. Generally, similar findings have been reported by the other groups that have performed quantitative PCR tissue distribution analyses of the hTLRs, with agreement that TLR9 mRNA is absent or only weakly detectable in adrenal gland, CNS, heart, kidney, liver, lung, pancreas, placenta, prostate, salivary gland, small intestine, spinal cord, testis, thyroid gland, trachea, and uterus. Unfortunately, the cellular patterns of TLR expression vary between different species, so the results of TLR stimulation in one species may not be predictive of what will occur in another. For example, mice differ from primates in that they express TLR9 not only in pDC and B cells, but also in monocytes and myeloid DC (reviewed in). This makes it difficult at best to use observations with CpG cialis jelly in murine studies to predict accurately the effects of TLR9 activation in humans. In contrast to hTLR9, hTLR7 and hTLR8 appear to have a broader cell-type-specific expression. TLR7 RNA expression seems to be strongest in human pDC and B cells, and at least low hTLR7 RNA expression was reported in, for example, monocytes, monocyte-derived DC, mDC, and macrophages, although other reports showed lack of TLR7 expression from all or some of these cell types. In contrast to hTLR7, hTLR8 RNA was readily observed in monocyte-derived DC, mDC, macrophages, Langerhans cells, or regulatory T cells , and was maximal in CD14+mononuclear cells, but could not be detected in pDC and B cells. Therefore, hTLR7 and hTLR9 colocalize in pDC and B cells, whereas hTLR8 and hTLR7 seem to be expressed in myeloid cells. Both receptors appear not be expressed in other cell types such as human NK cells and T cells, although some conflicting reports describe their RNA expression or lack of expression in these cell types. Nevertheless, owing to the lack of appropriate antibodies it is difficult to judge functional TLR7/8 protein expression in the tested cells. In addition to the reported unfunctionality of murine mTLR8 , mTLR7 appears to be expressed in a wide variety of cells including murine pDC, CD8 DC, B cells, regulatory T cells and macrophages. TLR7 expression was also observed in CD8 DC or T cells, although these cells did not respond to TLR7 activation. In both rodents and humans, administration of a CpG cialis jelly activates pDC to secrete IFN- , promoting Th1 adaptive immune responses. TLR9-stimulated B cells and pDC show increased expression of costimulatory molecules, resistance to apoptosis, upregulation of the chemokine receptor CCR7, and secretion of Th1-promoting chemokines and cytokines such as MIP-1, IP-10, and other IFN-inducible genes. These effects drive the migration and clustering of pDC in the T cell regions of lymph nodes and other lymphoid tissues. Coactivation of nanve, germinal center, or memory B cells through the B cell antigen receptor and TLR9 can be strong enough to drive their differentiation into antibody-secreting plasma cells. In the case of memory B cells, which have been stimulated previously, activation through TLR9 alone is sufficient to drive differentiation to plasma cells. We are unaware of any other single B cell mitogen that is as strong as an optimal B-Class CpG ODN, which has provided applications for CpG in promoting the production of antigen-specific human antibodies. The efficiency of hybridoma generation from purified primary human memory B cells is improved from 1-2% without a CpG cialis jelly to 30-100% with the addition of PF-3512676 (formerly known as CPG 7909 or cialis jelly 2006). CpG-induced plasma cell differentiation does not require T cell help, but its efficiency is enhanced further by interactions with pDC and by B cell receptor (BCR) crosslinking.